Insight Molecular Diagnostics

IMDXNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$135.479 M

$4.14 +3.24%

Close of 22 Sept 2026

Revenue

$4.05M

#3323 by revenue

Earnings

-$50.2K

Loss-making

Shares outstanding

32,724,284

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#10Alpha TeknovaTKNO$470.8M
#11Myriad GeneticsMYGN$384.5M
#12Insight Molecular DiagnosticsIMDX$135.5M
#13ImmucellICCC$90.7M
#14BiomericaBMRA$12.8M

What if Insight Molecular Diagnostics were worth as much as…

Open the what-if tool →

Gold $30.2T

$923,900.11

Per share 223,164× higher

Bitcoin $1.74T

$53,222.10

Per share 12,856× higher

Nvidia $5.52T

$168,552.72

Per share 40,713× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Insight Molecular Diagnostics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.